Chromosomal Abnormalities in Embryonic and Somatic Stem Cells
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The potential use of stem cells (SCs) for tissue engineering, regenerative medicine, disease modeling, toxicological studies, drug delivery, and as in vitro model for the study of basic developmental processes implies large-scale in vitro culture. Here, after a brief description of the main techniques used for karyotype analysis, we will give a detailed overview of the chromosome abnormalities described in pluripotent (embryonic and induced pluripotent SCs) and somatic SCs, and the possible causes of their origin during culture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilić, J., Pekarik, V., Tiscornia, G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1503 · Cited by 1,423 · cited 1×
“1, respectively) are the most frequent aberrations observed ( table 1 ) [Aasen et al., 2008; Mayshar et al., 2010; Boulting et al., 2011; MartinsTaylor and Xu, 2012; Peterson and Loring, 2014].”
Somatic coding mutations in human induced pluripotent stem cells
Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E., et al. (2011) · Nature · doi:10.1038/nature09805 · Cited by 1,273
Derivation of human embryonic stem cells in defined conditions
Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1177 · Cited by 1,114
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells
Mayshar, Y., Ben-David, U., Lavon, N., Biancotti, J.-C., Yakir, B., Clark, A. T., Plath, K., Lowry, W. E., & Benvenisty, N. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.07.017 · Cited by 756
Tarte, K., Gaillard, J., Lataillade, J.-J., Fouillard, L., Becker, M., Mossafa, H., Tchirkov, A., Rouard, H., Henry, C., Splingard, M., et al. (2010) · Blood · doi:10.1182/blood-2009-05-219907 · Cited by 430 · cited 1×
“…of chromosomes 13 and X (in 0.3–1.3% of cells analyzed) [BenDavid et al., 2011; Nikitina et al., 2011], trisomies of chromosome 5 and, less frequently, of chromosomes 8 and 20 (in 15–20% of cell analyzed) [Grigorian et al., 2010; Tarte et al., 2010] were reported after conventional G-banding.”
InfluentialHolzwarth, C., Vaegler, M., Gieseke, F., Pfister, S. M., Handgretinger, R., Kerst, G., & Müller, I. (2010) · BMC Cell Biology · doi:10.1186/1471-2121-11-11 · Cited by 314 · cited 1×
“%) seemed to significantly reduce the incidence of aneuploidies in hMSCs and promote the maintenance of genetic integrity [Holzwarth et al., 2010; Li et al., 2011; Tsai et al., 2011; Estrada et al., 2012]; whereas, in others, 1–5% O 2 concentrations were found to increase the risk of aneuploidies,…”
Estrada, J. C., Albo, C., Benguría, A., Dopazo, A., López-Romero, P., Carrera-Quintanar, L., Roche, E., Clemente, E. P., Enríquez, J. A., Bernad, A., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.172 · Cited by 297
Recurrent copy number variations in human induced pluripotent stem cells
Martins-Taylor, K., Nisler, B. S., Taapken, S. M., Compton, T., Crandall, L., Montgomery, K. D., Lalande, M., & Xu, R.-H. (2011) · Nature Biotechnology · doi:10.1038/nbt.1890 · Cited by 213
Wang, Y., Zhang, Z., Chi, Y., Zhang, Q., Xu, F., Yang, Z., Meng, L., Yang, S., Yan, S., Mao, A., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.480 · Cited by 185 · cited 1×
“Finally, data on chorionic villi-, human umbilical cord- and amniotic fluid-derived MSCs showed normal chromosome complements after 6–10 passages [Poloni et al., 2011; Wang et al., 2013; Ruan et al., 2014] or after 150 days of cryopreservation [Angelo et al., 2012].”
Yang, X.-F., He, X., He, J., Zhang, L.-H., Su, X.-J., Dong, Z.-Y., Xu, Y.-J., Li, Y., & Li, Y.-L. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-59 · Cited by 112 · cited 1×
“Human adipose-derived MSC lines cultivated for more than 6 months seem to maintain chromosome stability [Meza-Zepeda et al., 2008; Ra et al., 2011; Yang et al., 2011].”
Tissue Stem Cells: New Tools and Functional Diversity
Grompe, M. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.04.006 · Cited by 54 · cited 2×
“, 2015], regenerative medicine [Grompe, 2012], disease modeling [Merkle and Eggan, 2013], toxicological studies, and drug delivery [Seiler and Spielmann, 2011; Liu et al.”
Cited by
An overall view of the most common experimental models for multiple sclerosis
Dedoni, S., Scherma, M., Camoglio, C., Siddi, C., Dazzi, L., Puliga, R., Frau, J., Cocco, E., & Fadda, P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106230 · Cited by 79
Rebuzzini, P., Zuccotti, M., Redi, C. A., & Garagna, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2171-8 · Cited by 35
Self-citationControversies regarding transplantation of mesenchymal stem cells
Velikova, T., Dekova, T., & Miteva, D. G. (2024) · World Journal of Transplantation · doi:10.5500/wjt.v14.i2.90554 · Cited by 12
Metadata
- Authors
- Rebuzzini, P., Zuccotti, M., Redi, C. A., & Garagna, S.
- Venue
- Cytogenetic and Genome Research
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 147
- Issue
- 1
- Pages
- 1-9
- ISSN
- 1424-859X (ISSN-L)
- 1424-8581
- OpenAlex
- W2180569590
- Cited by
- 48
- References
- 11
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.